Penny Dash's long-awaited review into safety and quality came out this week and put cost-effectiveness at the heart of implementing future recommendations from reviews and inquires.
We cover the biggest changes - including the scrapping of Healthwatch - and whether yet more upheaval will be worth it.
Also this week an update on the government's neighbourhood health plans as the next bit of the strategy is revealed.
